MétaCan
Menu
Back to cohort
Record W2624993069 · doi:10.1002/cjp2.75

A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine

2017· article· en· W2624993069 on OpenAlexafffund
Steve E. Kalloger, Maziar Riazy, Basile Tessier‐Cloutier, Joanna M. Karasinska, Dongxia Gao, Renata D’Alpino Peixoto, Setareh Samimi, Christine Chow, Hui‐Li Wong, John R. Mackey, Daniel J. Renouf, David F. Schaeffer

Bibliographic record

VenueThe Journal of Pathology Clinical Research · 2017
Typearticle
Languageen
FieldMedicine
TopicPancreatic and Hepatic Oncology Research
Canadian institutionsVancouver General HospitalUniversity of AlbertaBC Cancer AgencyCentre for Advancing Health OutcomesPancreas Centre (Canada)University of British Columbia
FundersBC Cancer Foundation
KeywordsGemcitabineOncologyMedicineInternal medicineBiomarkerTissue microarrayImmunohistochemistryAntibodyAdjuvantPancreatic ductal adenocarcinomaPredictive markerAdenocarcinomaPancreatic cancerPathologyCancerBiologyImmunology

Abstract

fetched live from OpenAlex

Abstract Expression of human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma (PDAC) has been postulated to be a marker of sensitivity to gemcitabine. However, heterogeneity in the studies attempting to quantify hENT1 expression in patients with PDAC treated with gemcitabine has yielded inconclusive results that impede the adoption of hENT1 expression as a predictive biomarker. Tissue microarrays consisting of PDAC specimens from 227 patients acquired between 1987 and 2013 annotated with treatment and outcome information were subjected to staining with two antibodies for hENT1 (10D7G2 and SP120) on a single automated platform and scored by two independent pathologists blinded to treatment and outcome. The resultant scores were subjected to individual predictive disease‐specific survival analysis and to unsupervised hierarchical clustering to generate a multi‐marker classification. Tumour cell staining prevalence using either SP120 or 10D7G2 was predictive of gemcitabine sensitivity ( p = 0.02; p = 0.01). When combined, three groups emerged, classified as SP120 Low _10D7G2 Low , SP120 Low _10D7G2 High , and SP120 High _10D7G2 High , in which adjuvant gemcitabine conferred median survival differences of 0.2, 0.8, and 1.5 ( p = 0.76, p = 0.06, p = 0.01) years, respectively. These results were largely replicated in multivariable analysis with the P value for the SP120 Low _10D7G2 High cluster achieving statistical significance ( p = 0.03). These data suggest that either antibody for hENT1 can be used to predict gemcitabine sensitivity in resected PDAC. However, using both antibodies adds valuable information that enables the stratification of patients who can expect to have a good, intermediate, and poor response to adjuvant gemcitabine.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.010
metaresearch head score (Gemma)0.004
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesScience and technology studies
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.007
Threshold uncertainty score0.998

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0100.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.000
Science and technology studies0.0000.005
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.172
GPT teacher head0.494
Teacher spread0.322 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations12
Published2017
Admission routes2
Has abstractyes

Explore more

Same venueThe Journal of Pathology Clinical ResearchSame topicPancreatic and Hepatic Oncology ResearchFrench-language works237,207